BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24844968)

  • 1. Cancer risks from diabetes therapies: evaluating the evidence.
    Li C; Kong D
    Pharmacol Ther; 2014 Oct; 144(1):71-81. PubMed ID: 24844968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New clinical data with metformin therapy in patients with diabetes mellitus].
    Jermendy G
    Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin: risk-benefit profile with a focus on cancer.
    Provinciali N; Lazzeroni M; Cazzaniga M; Gorlero F; Dunn BK; DeCensi A
    Expert Opin Drug Saf; 2015 Oct; 14(10):1573-85. PubMed ID: 26359221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and bone health.
    Antonopoulou M; Bahtiyar G; Banerji MA; Sacerdote AS
    Maturitas; 2013 Nov; 76(3):253-9. PubMed ID: 23628280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and pancreatic cancer.
    Cui Y; Andersen DK
    Endocr Relat Cancer; 2012 Oct; 19(5):F9-F26. PubMed ID: 22843556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.
    Gallagher EJ; LeRoith D
    Ann N Y Acad Sci; 2011 Dec; 1243():54-68. PubMed ID: 22211893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes, insulin, insulin analogues, and cancer].
    Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
    Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus and the risk of cancer.
    Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
    Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
    Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
    Gallagher EJ; LeRoith D
    Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):485-94. PubMed ID: 23974779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs.
    McFarland MS; Cripps R
    Pharmacotherapy; 2010 Nov; 30(11):1159-78. PubMed ID: 20973689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
    Bosi E
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and cancer.
    Chowdhury TA
    QJM; 2010 Dec; 103(12):905-15. PubMed ID: 20739356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term metformin usage and cognitive function among older adults with diabetes.
    Ng TP; Feng L; Yap KB; Lee TS; Tan CH; Winblad B
    J Alzheimers Dis; 2014; 41(1):61-8. PubMed ID: 24577463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin: taking away the candy for cancer?
    Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
    Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermogenesis and related metabolic targets in anti-diabetic therapy.
    Arch JR
    Handb Exp Pharmacol; 2011; (203):201-55. PubMed ID: 21484574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes.
    Wiernsperger NF
    Diabetes Metab; 1999 Jun; 25(2):110-27. PubMed ID: 10443322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the treatment of type 2 diabetes mellitus.
    Israili ZH
    Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.